FOLH1 and neoplasm: Regarding efficacy, OTL78 identified tumor-positive regions with high sensitivity both in vivo and ex vivo specimens, with the detection rate being higher in patients with higher PSMA expression, larger tumor volumes, and ISUP grade group ≥ 3.